The Influenza vaccines market represent an attractive market characterize by sturdy growth prospects. Increasing awareness, growing vaccination coverage in the emerging countries, rising government support for immunization against Seasonal Influenza and increased focus on the production of treatments for vulnerable populations by introducing new vaccines and vaccines with a better route of administration are the main drivers to galvanized Influenza vaccines market.
Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow with double digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and 2010 primarily driven by the global spread of H1N1 Influenza virus. However, strong demand of Influenza vaccines contracted in 2011 by more than 50% due to waning threat of swine flu epidemic.
United States remains the largest market for Seasonal Influenza vaccines. Japan and emerging countries like China, India and Brazil is likely to drive Influenza vaccines markets in the next 5 to 6 years. Netherlands and United Kingdom have achieved greater vaccinations coverage.
In the major Seasonal Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the highest sales figures and likely to maintain leadership position in the Seasonal Influenza vaccines market.
Renub Research study titled “Influenza Vaccines Market & Forecast - Worldwide Analysis” provides a comprehensive assessment of the fast-evolving, high-growth of World Influenza Vaccines Landscape. This 179 page report with 140 Figures and 7 Tables examines the following segments for Influenza Vaccines Market
Worldwide Influenza vaccines market (2009 - 2019)
Worldwide Seasonal Influenza vaccines market has been covered from (2009 – 2019)
Worldwide Swine Flu (H1N1) Influenza vaccines market has been covered from (2009 – 2011)
Worldwide number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
Top 30 countries number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
Top 30 countries Seasonal Influenza vaccines market (2008 – 2019)
Top Merger & Acquisition deals in Influenza Vaccines Market
Key drivers of growth in the Worldwide Influenza Vaccines Market
Key challenges faces by Influenza Vaccines Market
All the 30 Countries Studied in the Report are as Follows
1. United States
16. United Kingdom
30. New Zealand
Top 6 Seasonal Influenza Vaccines Sales Performance Studied in the Report are as Follows
1. Fluarix / Flulaval
5. Fluvirin / Flucelvax
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.